AATP

Agape ATPOTCPK:AATP Stock Report

Market Cap

US$3.0b

7D

n/a

1Y

n/a

Updated

16 Sep, 2021

Data

Company Financials
AATP fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health6/6
Dividends0/6

AATP Overview

Agape ATP Corporation, an investment holding company, provides health and wellness products and health solution advisory services in Malaysia.

Price History & Performance

Summary of all time highs, changes and price drops for Agape ATP
Historical stock prices
Current Share PriceUS$8.00
52 Week HighUS$8.00
52 Week LowUS$8.00
Beta0.28
1 Month Changen/a
3 Month Changen/a
1 Year Changen/a
3 Year Changen/a
5 Year Changen/a
Change since IPO33.33%

Recent News & Updates

Shareholder Returns

AATPUS HealthcareUS Market
7Dn/a-0.8%-0.6%
1Yn/a32.7%33.6%

Return vs Industry: Insufficient data to determine how AATP performed against the US Healthcare industry.

Return vs Market: Insufficient data to determine how AATP performed against the US Market.

Price Volatility

Is AATP's price volatile compared to industry and market?
AATP volatility
AATP Beta0.28
Industry Beta0.87
Market Beta1

Stable Share Price: Insufficient data to determine AATP's volatility over the past 3 months.

Volatility Over Time: Insufficient data to determine AATP's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
201635David Howhttps://www.agapeatpgroup.com

Agape ATP Corporation, an investment holding company, provides health and wellness products and health solution advisory services in Malaysia. The company offers three series of programs that consist of various services and products under the ATP Zeta Health Program, ÉNERGÉTIQUE, and BEAUNIQUE names. Its products include ATP1s Survivor Select that contains various essential nutrients required by the human body to maintain normal metabolism; ATP2 Energized Mineral Concentrate, a nutritional supplement, which supports and enhances nutritional biochemical activities; ATP3 Ionized Cal-Mag, a calcium and magnesium minerals supplement; ATP4 Omega Blend, an oil blend that provides a bio-effective balance of essential fatty acids, omega 3, and omega 6; ATP5 BetaMaxx, a natural immune enhancer; AGN-Vege Fruit Fiber, a nutrition-based formulation for intestines and stomach; AGP1 Iron to improve iron deficiency anemia; and YFA-Young Formula, an anti-aging and youthful maintenance supplement.

Valuation

Is Agape ATP undervalued compared to its fair value and its price relative to the market?

618.24x

Price to Book (PB) ratio


Share Price vs. Fair Value

Below Fair Value: AATP ($8) is trading above our estimate of fair value ($0.01)

Significantly Below Fair Value: AATP is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: AATP is unprofitable, so we can't compare its PE Ratio to the US Healthcare industry average.

PE vs Market: AATP is unprofitable, so we can't compare its PE Ratio to the US market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate AATP's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: AATP is overvalued based on its PB Ratio (618.2x) compared to the US Healthcare industry average (3.3x).


Future Growth

How is Agape ATP forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

12.9%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Agape ATP has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Past Performance

How has Agape ATP performed over the past 5 years?

1.6%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: AATP is currently unprofitable.

Growing Profit Margin: AATP is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: AATP is unprofitable, but has reduced losses over the past 5 years at a rate of 1.6% per year.

Accelerating Growth: Unable to compare AATP's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: AATP is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (32.2%).


Return on Equity

High ROE: AATP has a negative Return on Equity (-9.78%), as it is currently unprofitable.


Financial Health

How is Agape ATP's financial position?


Financial Position Analysis

Short Term Liabilities: AATP's short term assets ($4.6M) exceed its short term liabilities ($860.4K).

Long Term Liabilities: AATP's short term assets ($4.6M) exceed its long term liabilities ($157.4K).


Debt to Equity History and Analysis

Debt Level: AATP is debt free.

Reducing Debt: AATP had no debt 5 years ago.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: Whilst unprofitable AATP has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.

Forecast Cash Runway: AATP is unprofitable but has sufficient cash runway for more than 3 years, even with free cash flow being positive and shrinking by 22.9% per year.


Dividend

What is Agape ATP current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate AATP's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate AATP's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if AATP's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if AATP's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of AATP's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

0.7yrs

Average management tenure


CEO

David How (57 yo)

5.25yrs

Tenure

Mr. Kok Choong How also known as David, has been the Global Chief Executive Officer, President, Secretary, Treasurer and Director of Agape ATP Corporation since June 1, 2016. Mr. How served as the Chairman...


Leadership Team

Experienced Management: AATP's management team is not considered experienced ( 0.7 years average tenure), which suggests a new team.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Agape ATP Corporation's employee growth, exchange listings and data sources


Key Information

  • Name: Agape ATP Corporation
  • Ticker: AATP
  • Exchange: OTCPK
  • Founded: 2016
  • Industry: Health Care Distributors
  • Sector: Healthcare
  • Market Cap: US$3.012b
  • Shares outstanding: 376.45m
  • Website: https://www.agapeatpgroup.com

Number of Employees


Location

  • Agape ATP Corporation
  • 1705 – 1708, Faber Towers
  • Tower 2, Level 17
  • Kuala Lumpur
  • Wilayah Persekutuan
  • 58100
  • Malaysia

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/09/16 22:12
End of Day Share Price2021/09/13 00:00
Earnings2021/06/30
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.